Tomorrow at the International Society on Thrombosis and Haemostasis (ISTH) Congress, Dr. Remy Petersen from Amsterdam University Medical Center will present a poster on Intellia’s investigational #HAE program, titled “Reduction of plasma kallikrein by in vivo CRISPR-based gene editing of KLKB1 does not alter coagulation in patients with #hereditaryangioedema.” Learn more: https://www.isth2024.org/ #ISTH2024
Remy did a great job presenting the poster and representing the Intellia team that made this possible. Kudos!
This research on Intellia's investigational HAE program presented by Dr. Remy Petersen at the ISTH Congress appears to be a significant step forward in understanding the effects of CRISPR-based gene editing on hereditary angioedema. The findings suggest promising implications for the management of this condition without impacting coagulation, which could potentially lead to improved treatment options for patients.